Assessment of response to treatment in vulvar vestibulitis syndrome by means of the vulvar algesiometer

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 1, 1999, Pages 99-102

  Eva, Lois J ^b   Reid, Wendy M N ^b   MacLean, Allan B ^a   Morrison, George D ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Algesiometer; Treatment response; Vulvar vestibulitis syndrome

Indexed keywords

CLOBETASONE BUTYRATE; ESTROGEN; NYSTATIN; OXYTETRACYCLINE; TRIMOVATE; UNCLASSIFIED DRUG;

ALGESIOMETER; ARTICLE; CLINICAL ARTICLE; DEVICE; FEMALE; HUMAN; PAIN; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; VULVAR VESTIBULITIS;

EID: 0032816381     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70442-4     Document Type: Article

References (5)

1. 1. McKay M, Frankman O, Horowitz BJ, Lecart C, Micheletti L, Ridley CM, et al. Vulvar vestibulitis and vestibular papillomatosis. Report of the ISSVD Committee on Vulvodynia. J Reprod Med 1991;36:413-5.
2. 2. Reid WM, MacLean AB. Vulvar pain. Contemp Rev Obstet Gynecol 1995;7:44-51.
3. 3. Goetsch MF. Vulvar vestibulitis syndrome: prevalence and historic features in a general gynecologic population. Am J Obstet Gynerol 1991;164:1609-14.
4. 4. Curnow JS, Barron L, Morrison G, Sergeant P. Vulval algesiometer. Med Biol Eng Comput 1996;34:266-9.
5. 5. Morrison GD, Adams SJ, Curnow JS, Parsons RJ, Sargeant P, Frost TA. A preliminary study of topical ketoconazole in vulval vestibulitis syndrome. J Dermatol Treatment 1996;7:219-21.